| Sources | Names Used |
|---|---|
| GDSC1000 | QL-VIII-58 |
| PharmacoGx | QL-VIII-58 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZBP1 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | HDLBP | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | RUNDC3B | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | DSCAML1 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | CDX2 | GDSC1000 | pan-cancer | AAC | -0.27 | 4e-05 |
| mRNA | HAAO | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | FZD2 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | FGF14 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | CACNA1D | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | ABLIM2 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-05 |
